EMA Risk Management Information Day

The focus of this interactive Information Day will be to exchange first experiences on the implementation of the revised GVP module XVI guideline on risk minimisation measures from different stakeholders' perspectives.

Back to Agenda

Session 2 - first experiences and practical aspects

Speaker(s)

Revised GVP Module XVI - impact research from a regulatory perspective

Liana Martirosyan

Medicines Evaluation Board (MEB), Netherlands

PRAC Member

Have an account?

Download registration form Register Now (Credit Card)

EMA Risk Management Information Day

Session 2 - first experiences and practical aspects

Speaker(s)

Revised GVP Module XVI - impact research from a regulatory perspective

Be informed and stay engaged.